Duggan MA - Search Results

1

Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S. Tota JE, et al. Among authors: duggan ma. Prev Med. 2017 May;98:5-14. doi: 10.1016/j.ypmed.2016.11.029. Epub 2017 Feb 6. Prev Med. 2017. PMID: 28279264

2

A paired comparison of dot blot hybridization and PCR amplification for HPV testing of cervical scrapes interpreted as CIN 1.

Duggan MA, Inoue M, McGregor SE, Stuart GC, Morris S, Chang-Poon V, Schepansky A, Honore L. Duggan MA, et al. Eur J Gynaecol Oncol. 1994;15(3):178-87. Eur J Gynaecol Oncol. 1994. PMID: 7957322

3

An audit of the cervical cancer screening histories of 246 women with carcinoma.

Duggan MA, Nation J. Duggan MA, et al. J Low Genit Tract Dis. 2012 Jul;16(3):263-70. doi: 10.1097/LGT.0b013e31823da811. J Low Genit Tract Dis. 2012. PMID: 22297213

4

Commentary on "Cervical cancer screening in England: the past, present, and future": a comparison with Canada.

Duggan MA. Duggan MA. Cancer Cytopathol. 2012 Apr 25;120(2):97-101. doi: 10.1002/cncy.20201. Epub 2012 Feb 24. Cancer Cytopathol. 2012. PMID: 22367793 Free article.

5

Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.

Tota JE, Bentley J, Blake J, Coutlée F, Duggan MA, Ferenczy A, Franco EL, Fung-Kee-Fung M, Gotlieb W, Mayrand MH, McLachlin M, Murphy J, Ogilvie G, Ratnam S. Tota JE, et al. Among authors: duggan ma. Prev Med. 2017 May;98:15-20. doi: 10.1016/j.ypmed.2016.11.030. Epub 2017 Feb 6. Prev Med. 2017. PMID: 28279257

6

Nonisotopic human papillomavirus DNA typing of cervical smears obtained at the initial colposcopic examination.

Duggan MA, Inoue M, McGregor SE, Gabos S, Nation JG, Robertson DI, Stuart GC. Duggan MA, et al. Cancer. 1990 Aug 15;66(4):745-51. doi: 10.1002/1097-0142(19900815)66:4<745::aid-cncr2820660425>3.0.co;2-x. Cancer. 1990. PMID: 2167143

7

The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis.

Duggan MA, McGregor SE, Benoit JL, Inoue M, Nation JG, Stuart GC. Duggan MA, et al. Hum Pathol. 1995 Mar;26(3):319-25. doi: 10.1016/0046-8177(95)90065-9. Hum Pathol. 1995. PMID: 7890285

8

Age is prognostic variable in cervical squamous cell carcinoma.

Robertson D, Fedorkow DM, Stuart GC, McGregor SE, Duggan MA, Nation G. Robertson D, et al. Among authors: duggan ma. Eur J Gynaecol Oncol. 1993;14(4):283-91. Eur J Gynaecol Oncol. 1993. PMID: 8344321

9

Human papillomaviruses in gynecological cancer.

Duggan MA. Duggan MA. Curr Opin Obstet Gynecol. 1996 Feb;8(1):56-62. Curr Opin Obstet Gynecol. 1996. PMID: 8777260 Review.

10

The HPV determinants of CIN I.

Duggan MA, McGregor SE, Stuart GC, Morris S, Chang-Poon V, Schepansky A, Honore L. Duggan MA, et al. Eur J Gynaecol Oncol. 1997;18(2):117-23. Eur J Gynaecol Oncol. 1997. PMID: 9105860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters